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We recently have shown that activated Ras, but not
Raf, causes transformation of intestinal (RIE-1, IEC-6)
epithelial cells, whereas both activated Ras and Raf
transform NIH 3T3 fibroblasts (Oldham, S. M., Clark, G.
J., Gangarosa, L. M., Coffey, R. J., and Der, C. J. (1996)
Proc. Natl. Acad. Sci. U. S. A. 93, 6924–6928). The obser-
vations that conditioned medium from Ras-, but not
Raf-, transfected RIE-1 cells, as well as exogenous trans-
forming growth factor a (TGFa), promoted morphologi-
cal transformation of parental RIE-1 cells prompted us
to identify epidermal growth factor (EGF) receptor
(EGFR) ligands produced by Ras-transformed RIE-1
cells responsible for this autocrine effect. Since studies
in fibroblasts have shown that v-Src is transforming, we
also determined if v-Src could transform RIE-1 cells. H-
or K-Ras-transformed cells secreted significant amounts
of TGFa protein, and mRNA transcripts for TGFa, am-
phiregulin (AR), and heparin-binding EGF-like growth
factor (HB-EGF) were induced. Like Ras, v-Src caused
morphological and growth transformation of parental
RIE-1 cells. However, TGFa protein was not secreted by
RIE-1 cells stably expressing v-Src or activated Raf, and
only minor increases in EGFR ligand mRNA expression
were detected in these cells. A selective EGFR tyrosine
kinase inhibitor PD153035 attenuated the Ras-, but not
Src-, transformed phenotype. Taken together, these ob-
servations provide a mechanistic and biochemical basis
for the ability of activated Ras, but not activated Raf, to
cause transformation of RIE-1 cells. Finally, we suggest
that an EGFR-dependent mechanism is necessary for
Ras, but not Src, transformation of these intestinal epi-
thelial cells.
A remarkable convergence of biological, biochemical and ge-
netic evidence has established that Ras proteins mediate many
of their actions via recruitment of Raf-1 to the cell surface,
which allows this serine/threonine kinase then to become acti-
vated. Raf-1 causes activation of a mitogen-activated protein
kinase (MAPK)1 kinase (MEK), which in turn phosphorylates
p42 and p44 MAPKs. These two MAPKs then translocate to the
nucleus where they activate the Elk-1 transcription factor. The
ability of dominant negative mutants of Raf-1, MEK, and
MAPKs to block oncogenic Ras transformation of rodent fibro-
blasts demonstrates the essential role of this kinase cascade in
Ras function (1–4). However, recent studies also support the
importance of Raf-independent effector pathways in mediating
Ras transformation (4–6).
Although mutated ras genes are most frequently associated
with human tumors of epithelial origin (7, 8), most of our
knowledge on the signaling pathways that mediate oncogenic
Ras function is based on studies of rodent fibroblasts. There-
fore, we have been interested in examining transformation by
oncogenes such as ras, raf, and src in epithelial cell systems.
We have observed that activated Ras, but not Raf, causes
transformation of the rat intestinal epithelial cell line RIE-1, as
determined by altered morphology, growth in soft agar, and
rapid appearance of tumors in nude mice (9). Thus, activation
of the Raf/MEK/MAPK cascade alone was not sufficient to
cause transformation. Furthermore, our observation that Ras-,
but not Raf-, expressing cells secreted factors that promoted
RIE-1 morphological transformation suggested that Ras trans-
formation of these epithelial cells was mediated, at least in
part, via an autocrine mechanism. Previous studies in other
systems have found increased expression of transforming
growth factor-a (TGFa) associated with Ras transformation
(10–12).
In the present study, we have evaluated the role of EGF
receptor (EGFR) ligands in mediating Ras transformation of
RIE-1 cells. We observed that Ras-, but not Raf-, expressing
cells exhibited increased expression and secretion of TGFa
protein. In contrast, Src transformation did not cause up-reg-
ulation of TGFa production. Furthermore, inhibition of EGFR
function impaired the morphological and growth characteris-
tics of Ras-, but not Src-, transformed cells. These observations
distinguish the activities of Ras versus Raf and suggest that
Ras transformation is mediated by a Raf-independent, EGFR-
dependent mechanism. Transformation by v-Src, however, is
not dependent on an EGFR autocrine mechanism.
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MATERIALS AND METHODS
Cell Lines and Reagents
RIE-1 cells were obtained from Dr. Kenneth Brown (Cambridge, UK)
and are a diploid, nontransformed, EGF-responsive cell line derived
from rat small intestine (13, 14). Cells were grown in Dulbecco’s mod-
ified Eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum (Invitrogen). All assays were done before passage 30. The EGFR
kinase inhibitor PD153035 was obtained from Parke-Davis (15).
Constructs and Transfections
The pZIP-K-ras(12V) and pZIP-Draf22W retrovirus expression
vector constructs, which encode transforming mutants of human
K-Ras 4B and Raf, respectively, have been described (9, 16). The
pSV2-H-ras (12V) expression vector construct contains the genomic
human sequences encoding the transforming H-Ras(12V) protein and
was provided by Dr. Jorge Filmus (Sunnybrook Health/Science Ctr.,
Toronto, Canada) (17). The psrc construct encodes viral Src and was a
gift from Dr. Mark Kamps (VCSD, San Diego, CA) (18). The constructs
pZIP-K-ras(12V), pZIP-Draf22W, and psrc with pZIP-NeoSV(x)1, as
well as the pZIP-NeoSV(x)1 vector control, were each transfected into
the RIE-1 cells (1–3 mg of plasmid DNA/60-mm dish). Transfections
were done using 5 ml of LipofectAMINE (Life Technologies, Inc.) for
16–20 h on cells seeded at 1–5 3 105/60-mm dish. Transfected cells
were selected and maintained in medium containing 400 mg/ml G418
(Life Technologies, Inc.). Multiple G418-resistant colonies (.50) were
pooled together for further studies. The pSV2-H-ras (12V) as well as the
pSV2neo vector control were each transfected into the RIE-1 cells by
calcium phosphate precipitation as described previously (19). Trans-
fected cells were selected in medium containing 500 mg/ml of G418 (Life
Technologies, Inc.) and subcloned by limiting dilution.
TGFa Radioimmunoassay
Parental RIE-1 cells and each of the transfected RIE-1 lines were
grown to confluence in 24-well dishes, washed in isotonic buffer twice,
and switched to serum-free DMEM (1 ml/well) for 48 h, at which time
media and lysates were harvested. The cells were washed twice with
isotonic buffer and then lysed at room temperature in 25 mM Tris-HCl
(pH 8.0), 50 mM NaCl, 0.5% sodium deoxycholate, and 0.5% Nonidet
P-40 (1 ml/well) on a rocker for 1 h. The rat TGFa antibody used for the
RIA was developed in collaboration with East Acres Biologicals (South-
bridge, MA). The RIA has been described previously in detail (20) and
was used to measure TGFa in both the conditioned media and lysates of
each transfected cell line. Representative wells were trypsinized, and
the cells were counted with a hemacytometer to normalize the data.
These experiments were performed on cell lines prior to passage 11.
Isolation of Poly(A)1 RNA and Northern Blot Analysis
Cells were grown to near confluence, washed twice with isotonic
buffer, and then switched to serum-free DMEM for 72 h. Then total
cellular RNA was extracted by the method of Schwab et al. (21). Oli-
go(dT)-selected RNA was separated by electrophoresis in 1.2% agarose/
formaldehyde gels, and Northern blotting was performed as described
previously (22, 23). Hybridizations with species-specific probes labeled
by RNA polymerase-directed reverse transcription (EGF, TGFa, amphi-
regulin (AR), betacellulin (BTC), and 1B15) or random primer extension
(heparin-binding EGF-like growth factor (HB-EGF)) were performed in
hybridization ovens as described previously (24, 25). 1B15 is a consti-
tutively expressed sequence previously described (26). PhosphorImager
analysis (Molecular Dynamics) was performed to quantify band
intensities.
Growth Assays
Anchorage-dependent—Parental, H-Ras, K-Ras, and v-Src RIE-1
cells were plated in 6-well cluster plates at a density of 1 3 106
cells/well. Cells were counted 24 h later to determine plating efficiency.
Cells were then treated with the indicated concentrations of PD153035
(10 nM, 25 nM, and 50 nM) or Me2SO (1 ml/ml). Cells were treated every
other day (days 2 and 4), and triplicate wells were counted by hemacy-
tometer on days 3 and 6.
Anchorage-independent—1–20 3 103 cells/ml of each cell line (H-ras-,
K-ras-, or v-src-transfected RIE-1 cells) were plated in 0.4% SeaPlaque
agarose (FMC Corp. BioProducts) over a hardened layer of 0.8% aga-
rose. Growth medium containing Me2SO alone or PD153035 (dissolved
in Me2SO) was added prior to plating. After 7–10 days, colonies in
triplicate (.50 mm) were counted with a colony counter (Bausch &
Lomb). Paired t test was used to test for significant differences com-
pared with control.
Morphology Experiments
Morphological reversion experiments were performed by adding 1 mM
PD153035 or Me2SO in growth medium to ;50% confluent ras-and
v-src-transfected RIE-1 cells growing in 6-well dishes. Morphological
changes were monitored over the next 72 h and photographs were
taken. Conditioned media experiments were performed by harvesting
48-h serum-free conditioned medium from the Ras-transformed and
control cell lines. The conditioned media were then filtered through a
0.2 micron filter and added to 50% confluent parental RIE-1 cells at a
3:1 ratio with fresh serum-free medium alone or with 1 mM PD153035 or
3 ml/ml anti-TGFa antibody S-574. The cells were examined for mor-
phological changes over the next 48 h and photographed.
EGFR Analysis
Parental and H-Ras RIE-1 cells were plated in 24-well cluster dishes
at a density of 1 3 105 cells/well and allowed to grow to 70–80%
confluence. Cells were then treated for 24 h with 1 mM PD153035 or
Me2SO followed by a 5-min pulse with TGFa (10 ng/ml) where indi-
cated. Cells were then lysed with buffer containing 20 mM Hepes, pH
7.4, 1% (w/v) Triton X-100, 2 mM EGTA, 2 mM EDTA, 500 mM Na3VO4,
50 mM PMSF, 10 mg/ml aprotinin, and 10 mg/ml leupeptin. Samples of
equal protein concentrations were run on SDS-polyacrylamide gel elec-
trophoresis and Western blotted onto polyvinylidene difluoride mem-
branes. The Western blot was probed with anti-human EGFR sheep
polyclonal (Upstate Biotechnology) and detected with a donkey anti-
sheep horseradish peroxidase-conjugated IgG secondary antibody
(Jackson Laboratories) followed by ECL chemiluminescence (Amer-
sham Life Science Inc.) and autoradiography. The phosphorylated ty-
rosine content of the receptor was determined by subsequently probing
the Western blot with an horseradish peroxidase-conjugated anti-phos-
photyrosine, clone 4G10 (Upstate Biotechnology), followed by ECL
chemiluminescence detection (Amersham Life Science Inc.) and
autoradiography.
RESULTS
v-Src, Like Activated Ras, Transforms RIE-1 Cells—We re-
cently have reported that constitutively activated Ras, but not
Raf, caused transformation of RIE-1 cells and that Ras-condi-
FIG. 1. Morphology of parental
RIE-1 cells and oncogene-transfected
RIE-1 cells. Cell lines were generated
and maintained as discussed under “Ma-
terials and Methods.” A, RIE-1 cells; B,
RIE-1 pSV2neo cells; C, RIE-1 pZIP-raf
22W cells; D, RIE-1 pSV2-H-ras (12V)
cells; E, RIE-1 pZIP-K-ras (12V) cells; and
F, RIE-1 pZIP/v-src cells. Magnification 3
200.
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tioned medium morphologically transformed parental RIE-1
cells (9). Since studies in fibroblasts have demonstrated that
v-Src causes transformation, we examined whether RIE-1 cells
were also transformed by v-Src. A line of RIE-1 cells was
generated with a v-src construct. We initially compared the
morphological appearance of the parental RIE-1 cells (Fig. 1A)
with that of those transfected with pSV2-H-ras(12V) (Fig. 1D),
pZIP-K-ras(12V) (Fig. 1E), and psrc (Fig. 1F). RIE-1 cells stably
expressing oncogenic H-Ras, K-Ras, and v-Src showed morpho-
logical alterations from a flat monolayer of cuboidal cells to
spindle-shaped cells with a poorly adherent, highly refractile
subpopulation. The H-Ras- and v-Src-expressing RIE-1 cells,
like the recently described K-Ras-expressing RIE-1 cells (9),
also grew in soft agar and formed tumors rapidly in nude mice
(data not shown). The RIE-1 cells transfected with pZIP-
Draf22W (Fig. 1C), the pSV2neo vector (Fig. 1B), and the
pZIP-Neo SV(x)1 vector (data not shown) appeared identical in
morphology to parental cells. Thus, in contrast to activated Raf,
v-Src caused a fully transformed phenotype that was similar to
that caused by activated Ras.
TGFa Production by Activated Ras-, but Not Raf- or Src-,
Expressing RIE-1 Cells—Studies then were directed toward
identification of factors that contribute to the morphological
changes induced by Ras-conditioned medium. Since adminis-
tration of TGFa to parental RIE-1 cells led to morphological
alterations similar to Ras-conditioned medium (9), we initially
examined TGFa protein production by Ras-transformed cells
and compared the results with raf- and src-transfected cells.
RIE-1 cells transfected with activated H-ras and K-ras secreted
;3–6 ng of TGFa/106 cells/48 h into conditioned media, and
;500–1000 pg of TGFa/106 cells were measured in cell lysates
(Fig. 2). Neither the parental RIE-1 cells nor the cells trans-
fected with activated raf, v-src, or control vectors had detecta-
ble TGFa in their conditioned media (Fig. 2). Less than 100 pg
of TGFa/106 cells was detected in cell lysates of pZIPneo-, raf-,
and v-src-transfected RIE-1 cells. Thus, production of TGFa
clearly distinguishes Ras- from Raf-expressing RIE-1 cells.
Furthermore, v-Src-mediated transformation was not associ-
ated with increased TGFa protein levels, and thus, production
of TGFa is not required for RIE-1 cellular transformation.
Administration of a neutralizing TGFa antibody to Ras-condi-
tioned medium was able to partially revert morphological
transformation of parental RIE-1 cells (Fig. 6C) although it was
able to completely block the effects of exogenous TGFa (data
not shown), suggesting that additional factors participate in
Ras morphological transformation.
Ras, Src, and Raf Exhibit Differential Expression of EGFR
Ligands—We have reported previously that EGFR ligand ex-
pression is coordinantly regulated in parental RIE-1 cells (27),
and up-regulation of several EGFR ligands has been observed
in keratinocytes infected with v-H-ras (12). Inasmuch as reli-
able protein assays are not available for AR and HB-EGF, we
examined expression of mammalian EGFR ligands by North-
ern blot analysis. Poly(A)1 RNA was isolated from near conflu-
ent cultures of each cell line maintained serum-free for 72 h.
Primary data are shown in Fig. 3A and phosphoimager quan-
tification of band intensities are depicted in Fig. 3B. Results
are expressed as -fold increase over appropriate neo control,
after normalization to the constitutively expressed 1B15
mRNA of each lane. The only transcript detected in parental
RIE-1 cells and RIE-1 cells transfected with vector controls was
HB-EGF. RIE-1 cells transfected with H-ras and K-ras con-
structs exhibited a greater than 10-fold induction of signals for
AR and TGFa and a 2–3-fold increase in HB-EGF mRNA
expression. In contrast to Ras-transformed cells, raf- and v-src-
transfected cells had less than a 2-fold increase in AR and
HB-EGF expression. A TGFa transcript was observed in v-Src-
transformed cells although no TGFa protein was detected as
noted above. Transcripts for EGF and BTC were not seen in
any of the cell lines. Thus, selective overexpression of TGFa,
FIG. 2. TGFa protein production in conditioned media and cell
lysates of parental and oncogene-transfected RIE-1 cells. TGFa
protein was measured by RIA in 48-h serum-free conditioned medium
and cell lysates as described under “Materials and Methods.”
FIG. 3. mRNA expression of EGFR ligands in parental and
oncogene- transfected RIE-1 cells. Poly(A)1 RNA was isolated from
near confluent cultures incubated in serum-free medium for 72 h. Two
mg of RNA were loaded per lane. Northern blots were prepared and
probed with 32P-labeled complementary sequences as described in “Ma-
terials and Methods.” Blots were scanned with a phosphoimager to
obtain quantification of band intensities. The transcript signals of each
lane were normalized to the 1B15 loading control signal in that lane. A,
northern blot; B, relative EGFR ligand expression represented as -fold
increase over neo control.
FIG. 4. Effects of EGFR tyrosine kinase inhibition on TGFa-
induced and basal EGFR tyrosine phosphorylation in parental
and Ras-transformed RIE-1 cells. Parental and H-Ras RIE-1 cells
were treated for 24 h with 1 mM PD153035 or Me2SO (control, CTL) and
then pulsed with TGFa (10 ng/ml). Cells were lysed, and samples of
equal protein content were electrophoresed on SDS-polyacrylamide
gels. Total EGFR and tyrosine-phosphorylated EGFR content were
determined separately by Western blot analyses using specific antibod-
ies as described under “Materials and Methods.”
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AR, and HB-EGF distinguishes Ras RIE-1 cells from both
nontransformed Raf and transformed v-Src RIE-1 cells.
EGFR Kinase Inhibition Selectively Alters the Morphology
and Growth of Ras-transformed RIE-1 Cells—PD153035 has
been demonstrated to be a highly specific EGFR tyrosine ki-
nase inhibitor (15). The ability of this compound to block EGFR
function in RIE-1 cells is shown in Fig. 4. Pretreatment with
PD153035 (1 mM) blocked TGFa-induced EGFR tyrosine phos-
phorylation in serum-starved parental RIE-1 cells (Fig. 4). This
agent was then used to determine the contribution of up-regu-
lated EGFR ligands to the Ras-transformed phenotype under
four experimental conditions. First, PD153035 (1 mM) reduced
basal EGFR tyrosine phosphorylation in H-Ras-transformed
RIE-1 cells (Fig. 4). Based on the previous data, we suggest that
this enhanced basal EGFR phosphorylation is likely due to
increased levels of endogenous EGF-like ligands activating the
EGFR in Ras-transformed cells. Second, addition of 1 mM
PD153035 to RIE-1 cells expressing activated K-Ras caused
morphological reversion to a more normal appearance within
72 h (Fig. 5). Third, addition of the compound to conditioned
medium from K-Ras-transformed cells prevented morphologi-
cal transformation of parental RIE-1 cells caused by K-Ras-
conditioned medium alone (Fig. 6). Finally, PD153035 caused a
dose-dependent reduction in the ability of H- and K-Ras-trans-
formed RIE-1 cells to proliferate on plastic (Fig. 7). We ob-
served, however, that PD153035 treatment of Src-transformed
cells failed to cause any significant morphological reversion
(Fig. 5) and did not inhibit the monolayer growth of these
Src-transformed cells or parental RIE-1 cells (Fig. 7). This
agent also significantly reduced soft agar growth of H- and
K-Ras-, but not v-Src-, transformed RIE-1 cells (data not
shown). Thus signaling through the EGFR contributes signifi-
cantly to Ras transformation of RIE-1 cells, but Src transfor-
mation does not appear dependent on this pathway.
DISCUSSION
These results provide a mechanism to explain why activated
Ras, but not activated Raf, transforms RIE-1 cells (9). Herein,
we have shown that there is up-regulation of EGFR ligand
expression in activated ras-, but not raf-, transfected RIE-1
cells and that autocrine growth factor signaling through the
EGFR contributes significantly to the Ras-transformed pheno-
type. Additional recent support for the importance of EGFR
signaling in mediating the Ras-transformed phenotype comes
from studies using EGFR “knock-out” keratinocytes infected
with H-ras retroviral constructs. As compared with H-ras-in-
fected, wild-type keratinocytes, H-ras-infected EGFR 2/2 cells
form smaller tumors in a primary engrafted papilloma model.2
The failure of Raf-expressing cells to cause induction of EGFR
ligand expression suggests that Ras activates a Raf-independ-
ent pathway that promotes EGFR ligand expression. Studies
are underway to identify the Ras signaling pathway that is
responsible for EGFR ligand overexpression.
These studies do not delineate the role of individual EGFR
ligands in contributing to the Ras-transformed phenotype. Fil-
mus et al. (28) studied H-ras transformation of an immature
rat epithelial crypt cell line (IEC-18) and also found TGFa
mRNA induction and increased protein production. Soft agar
growth of the H-ras-transfected IEC-18 cells was attenuated
with both TGFa neutralizing antibodies and anti-sense TGFa
construct transfection although transfection of IEC-18 cells
2 A. A. Dlugosz, R. J. Coffey, and S. H. Yuspa, unpublished
observations.
FIG. 6. Effects of TGFa antibody neutralization and EGFR ty-
rosine kinase inhibition on morphological alterations of paren-
tal RIE-1 cells induced by Ras-conditioned medium. Conditioned
medium from vector control or K-ras-transfected RIE-1 cells alone or
together with either anti-TGFa antibody (1:250) or PD153035 (1 mM)
was added to parental RIE-1 cells as described under “Materials and
Methods.” Photographs were taken 48 h later. A, control conditioned
medium; B, K-Ras-conditioned medium; C, K-Ras-conditioned medium
plus anti-TGFa antibody; D, K-Ras-conditioned medium plus
PD153035. Magnification 3 200.
FIG. 5. Effects of EGFR tyrosine ki-
nase inhibition on morphological ap-
pearance of K-Ras- and v-Src-trans-
formed RIE-1 cells. Me2SO (control) or
1 mM PD153035 was added to the growth
media as described under “Materials and
Methods,” and photographs of the cells
were taken 72 h later. A, K-Ras-trans-
formed RIE-1 cells plus control; B, K-Ras-
transformed RIE-1 cells plus PD153035;
C, v-Src-transformed RIE-1 cells plus con-
trol; D, v-Src-transformed RIE-1 cells
plus PD153035. Magnification 3 200.
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with TGFa was not sufficient to transform these cells. Expres-
sion of other EGFR ligands was not examined in this study.
The observation that EGFR blockade (via pharmacological in-
activation of its tyrosine kinase (Fig. 6D)), but not neutraliza-
tion of TGFa (via antibody neutralization (Fig. 6C)), is able to
fully revert morphological alterations induced by Ras-condi-
tioned medium suggests that secreted AR and HB-EGF con-
tribute to this effect. It is possible that TGFa along with AR
and/or HB-EGF act in concert to mediate morphological trans-
formation of RIE-1 cells. Future studies will address whether
overexpression of AR or HB-EGF may be sufficient to trans-
form RIE-1 cells or whether a combination of EGFR ligands is
necessary.
v-Src transformation of RIE-1 cells appears to be mediated
by a mechanism distinct from that of Ras. In contrast to events
related to Ras transformation of RIE-1 cells, v-Src cells do not
highly express EGFR ligand transcripts nor produce TGFa
protein, and administration of a specific EGFR tyrosine kinase
inhibitor did not lead to morphological reversion or a decrease
in growth of these Src-transformed cells. Collectively, these
data indicate that Src transformation of RIE-1 cells occurs
independently of EGFR-mediated events. Thus, whereas Src
transformation of rodent fibroblasts is dependent on Ras func-
tion, a similar requirement may not be involved in Src trans-
formation of RIE-1 cells. Ras-independent Src signaling events
have been observed recently (29, 30). Whether Ras activation is
required for Src transformation awaits future analyses.
These results in intestinal epithelial cells underscore the
potentially important distinct pathways and mechanisms un-
derlying oncogenic transformation of epithelial cells and fibro-
blasts. This is not unanticipated in view of marked differences
in the growth regulation of these two cell types. For example,
platelet-derived growth factor is a mitogen for fibroblasts, but
epithelial cells are nonresponsive due to their lack of platelet-
derived growth factor receptors. TGFb stimulates growth of
fibroblasts, whereas it is a potent epithelial cell growth inhib-
itor. Moreover, half-lives of farnesylated Ras proteins markedly
differ between fibroblasts and epithelial cells in the presence of
farnesyltransferase inhibitors.3 Finally, activated ras and raf
constructs transform NIH 3T3 fibroblasts, whereas only the
former is able to transform intestinal and mammary epithelial
cells (6). An important lesson from these studies is that one
cannot necessarily extrapolate results from growth regulation
and oncogene transformation of fibroblasts to epithelial cell
systems.
Acknowledgments—We thank Mark Kamps for the v-src expression
vector and Dick Leopold for providing the PD153035 EGF receptor
inhibitor.
REFERENCES
1. Kolch, W., Heidecker, G., Lloyd, P., and Rapp, U. R. (1991) Nature 349,
426–428
2. Cowley, S., Paterson, H., Kemp, P., and Marshall, C. J. (1994) Cell 77, 841–852
3. Khosravi-Far, R., Solski, P. A., Clark, G. J., Kinch, M. S., and Der, C. J. (1995)
Mol. Cell. Biol. 15, 6443–6453
4. Khosravi-Far, R., White, M. A., Westwick, J. K., Solski, P. A., Chrzanowska-
Wodnicka, M., Van Aelst, L., Wigler, M. H., and Der, C. J. (1996) Mol. Cell.
Biol. 16, 3923–3933
5. White, M. A., Nicholette, C., Minden, A., Polverino, A., Van Aelst, L., Karin,
M., and Wigler, M. H. (1995) Cell 80, 533–541
6. Joneson, T., White, M. A., Wigler, M. H., and Bar-Sagi, D. (1996) Science 271,
810–812
7. Clark, G. J., and Der, C. J. (1993) in GTPases in Biology I (Dickey, B. F., and
Birnbaumer, L., eds) pp. 259–288, Springer Verlag, Berlin
8. Bos, J. L. (1989) Cancer Res. 49, 4682–4689
9. Oldham, S. M., Clark, G. J., Gangarosa, L. M., Coffey, R. J., and Der, C. J.
(1996) Proc. Natl. Acad. Sci. U. S. A. 93, 6924–6928
10. Buick, R. N., Filmus, J., and Quaroni, A. (1987) Exp. Cell Res. 170, 300–309
11. Ciardello, F., McGeady, M. L., Kim, N., Basolo, F., Hynes, N., Langton, B. C.,
Yokozaki, H., Saeki, T., Elliott, J. W., Masui, H., Mendelsohn, J., Soule, H.,
Russo, J., and Salomon, D. S. (1990) Cell Growth & Differ. 1, 407–420
12. Dlugosz, A. A., Cheng, C., Williams, E. K., Darwiche, N., Dempsey, P. J.,
Mann, B., Dunn, A. R., Coffey, R. J., and Yuspa, S. H. (1995) Cancer Res. 55,
1883–1893
13. Blay, J., and Brown, K. D. (1984) Cell Biol. Int. Rep. 8, 551–560
14. Blay, J., and Brown, K. D. (1985) Biochem. J. 225, 85–94
15. Fry, D. W., Kraker, A. J., McMicheal, A., Ambroso, L. A., Nelson, J. M.,
Leopold, W. R., Connors, R. W., and Bridges, A. J. (1994) Science 265,
1093–1095
3 A. D. Cox, R. J. Coffey, and C. J. Der, unpublished observations.
FIG. 7. Effects of EGFR tyrosine kinase inhibition on anchorage-dependent growth of parental RIE-1 cells and its transformants.
Cells were plated on plastic as described under “Materials and Methods” either in the presence of increasing doses of PD153035 or Me2SO (control).
Cell number was determined by hemacytometer in triplicate wells.
Ras Transformation of RIE-1 Cells18930
16. Buss, J. E., Solski, P. A., Schaeffer, J. P., and MacDonald, M. J. (1989) Science
243, 1600–1603
17. Buick, R. N., Filmus, J., and Quaroni, A. (1987) Exp. Cell Res. 170, 300–309
18. Kamps, M. P., Buss, J. E., and Sefton, B. M. (1985) Proc. Natl. Acad. Sci.
U. S. A. 82, 4625–4628
19. Dempsey, P. J., and Coffey, R. J. (1994) J. Biol. Chem. 269, 16878–16889
20. Russell, W. E., Dempsey, P. J., Sitaric, S., Peck, A. J., and Coffey, R. J. (1993)
Endocrinology 133, 1731–1738
21. Schwab, M. K., Alitalo, H. E., Varmus, H. E., and Bishop, J. M. (1983) Nature
303, 497–501
22. Dobner, P. R., Kawaski, E. S., Yu, L. Y., and Bancroft, F. C. (1981) Proc. Natl.
Acad. Sci. U. S. A. 78, 2230–2234
23. Thomas, P. S. (1980) Proc. Natl. Acad. Sci. U. S. A. 77, 5201–5205
24. Coffey, R. J., Sipes, N. J., Bascom, C. C., Graves-Deal, R., Pennington, C. Y.,
Weisman, B. E., and Moses, H. L. (1988) Cancer Res. 48, 1596–1602
25. Melton, D. A., Kreig, D. A., Rebagliati, M. R., Maniatis, T., Zinn, K., and Green,
M. R. (1984) Nucleic Acids Res. 12, 7035–7056
26. Barnard, J. A., Beauchamp, R. D., Coffey, R. J., and Moses, H. L. (1989) Proc.
Natl. Acad. Sci. U. S. A. 86, 1578–1582
27. Barnard, J. A., Graves-Deal, R., Pittelkow, M. R., DuBois, R. N., Cook, P.,
Ramsey, G. W., Bishop, P. R., Damstrup, L., and Coffey, R. J. (1994) J. Biol.
Chem. 269, 22817–22822
28. Filmus, J., Shi, W., and Spencer, T. (1993) Oncogene 8, 1017–1022
29. Yu, C. L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz,
J., and Jove, R. (1995) Science 269, 81–83
30. D’Arcangelo G., and Halegoua S. (1993) Mol. Cell. Biol. 13, 3146–3155
Ras Transformation of RIE-1 Cells 18931
